CA
CBAY

Cliff Asness’s Cymabay Therapeutics CBAY Stock Holding History

Cliff Asness’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,270
Closed -$526K – 2528
2023
Q4 		$526K Sell
22,270
-9,839
-31% -$175K ﹤0.01% 1859
2023
Q3 		$479K Sell
32,109
-8,378
-21% -$111K ﹤0.01% 1861
2023
Q2 		$443K Buy
+40,487
New +$377K ﹤0.01% 1826
2021
Q4 		– Sell
-10,578
Closed -$39K – 2310
2021
Q3 		$39K Buy
+10,578
New +$41.7K ﹤0.01% 2229
2021
Q1 		– Sell
-90,221
Closed -$518K – 2285
2020
Q4 		$518K Buy
+90,221
New +$683K ﹤0.01% 1764
2020
Q1 		– Sell
-18,335
Closed -$36K – 2182
2019
Q4 		$36K Buy
+18,335
New +$68.9K ﹤0.01% 2104
2019
Q1 		– Sell
-21,993
Closed -$173K – 2237
2018
Q4 		$173K Sell
21,993
-18,603
-46% -$177K ﹤0.01% 2101
2018
Q3 		$450K Buy
40,596
+7
+0% +$87 ﹤0.01% 1986
2018
Q2 		$545K Buy
+40,589
New +$508K ﹤0.01% 1951

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cliff Asness's CBAY Position: Q1 2024 in Review

Cliff Asness sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 22,270 shares — an estimated $526K sold.

Cliff Asness first reported a position in CBAY in Q2 2018 and held it in 9 quarters. The position peaked at $545K in Q2 2018. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Cliff Asness reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Cliff Asness sold 22,270 Cymabay Therapeutics shares in Q1 2024, an estimated $526K.
  • Cliff Asness first reported a position in Cymabay Therapeutics in Q2 2018 and held it in 9 quarters.
  • Cliff Asness's Cymabay Therapeutics position peaked at $545K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on AQR Capital Management's 13F filing for Q1 2024, filed 15 May 2024.